Skip to main content

Table 1 Baseline characteristics of two groups

From: Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system is effective for long-term management of adenomyosis

 

Group A (n = 70)

Group B (n = 69)

P

Age (years)

39.4 (38.4–40.4)

39.5 (38.2–40.8)

.576

BMI (kg/ m^2)

22.9 ± 2.92

22.6 ± 2.28

.418

Uterine volume (cm^3)

189 0.1(171.1-207.2)

178.2 (158.8-197.6)

.204

Maximum diameter (cm)

56.5 (53.5–59.5)

55.0 (52.3–57.8)

.549

Nullipara, n(%)

9 (12.9%)

13 (18.8%)

.352

Multipara, n(%)

61 (87.1%)

56 (81.2%)

Number of abortions, n

1.4 (1.1–1.8)

1.3 (0.9–1.7)

.460

Previous abdominal surgery, n(%)

 Cesarean section

27 (38.6%)

34 (49.3%)

.204

 Myomectomy

1 (1.4%)

1 (1.4%)

>.99

 Appendectomy

1 (1.4%)

0

>.99

 Adnexal surgery

4 (5.7%)

8 (11.6%)

.243

Preoperative hemoglobin, g/dL

115.1 ± 13.3

116.6 ± 13.5

.487

Preoperative CA125, U/ml

138.5 (106.6-170.4)

104.3 (84.8-123.9)

.311

Preoperative VAS score

7.7 (7.2–8.2)

7.1 (6.5–7.8)

.150

Preoperative MVJ score

4.7 (4.4-5.0)

4.5 (4.2–4.8)

.292

MVJ ≥ 5, n %

47 (67.1%)

40 (58.0%)

.296

Severe Dysmenorrhea (VAS ≥ 7), n %

58 (82.8%)

56 ( 81.2%)

.794

Follow-up period,month

62.9 (58.9–66.9)

56.2 (50.8–61.7)

 

Follow-up range,month

24, 101

24, 141

 
  1. Abbreviation: BMI Body mass index (calculated as weight in kilograms divided by the square of height in meters), CA125 Carbohydrate antigen 125, VAS Visual analog scale